Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Cells Tissues Organs

in vivo, in vitro

Guidelines for Authors
www.karger.com/cto_guidelines

Aims and Scope
Topics of Special Interest
Types of Papers
Research on Human Pluripotent Stem Cells
Submission
Conditions
Plagiarism Policy
Format and Arrangement
References
Further Details
Proofs
Digital Object Identifier (DOI)
Supplementary Material
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

Proofs
E-pub First
Reprints



Aims and Scope

'Cells Tissues Organs' is an international forum for communication among scientists interested in current research on functional morphology and morphogenesis at all levels of organization, from subcellular to macroscopy, with emphasis on humans and higher vertebrates. The journal offers rapid exchange of novel and significant information gained from experimental and theoretical investigations on all aspects that are pertinent to the formation and transformation of biological structure.



Topics of Special Interest

Developmental and reproductive biology, cell biology, tissue engineering, artificial organs, in vitro systems and transplantation. Papers highlighting the links between structural and functional aspects are preferred.



Types of Papers

The journal publishes:
(1) Original papers on experimental research.
(2) Theoretical contributions. These will appear in the section ‘Hypotheses and Concepts’ and may include provocative hypotheses, provided that they are innovative, well founded and show promise for new avenues of research.
(3) Reviews.
Suggestions concerning reviews on current topics of high interest are welcome.
All manuscripts must be accompanied by a covering letter signed by all authors. Assurance should be given that the manuscript is not under simultaneous consideration by any other publication. Reported studies using animal and human subjects must have been approved by the appropriate institutional review boards.



Research on Human Pluripotent Stem Cells

Research involving human embryonic stem cells, embryonic germ cells or induced pluripotent stem cells must comply with the ISSCR 'Guidelines for the Conduct of Human Embryonic Stem Cell Research' (website, PDF) or an equivalent set of guidelines or applicable regulations. Confirmation of this should be included in the manuscript as well as in the cover letter.



Submission

Manuscripts to 'Cells Tissues Organs' should be submitted online!

Before submitting your manuscript, you are encouraged to review the detailed guidelines here for specific directions as how to get a manuscript ready for submission.

Should you have any problems with your submission, please contact the editorial office:

Angela Lorenz
Editorial Office 'Cells Tissues Organs'
S. Karger AG
P.O. Box
CH–4009 Basel (Switzerland)
Tel. +41 61 306 1358
Fax +41 61 306 1434
cto@karger.com



Conditions

All manuscripts are subject to peer review.

Names, postal and e-mail addresses of four experts in the appropriate area of research should accompany each manuscript. At the Editors' discretion scientist(s) selected from this list may be invited to act as referee(s). Referees suggested should not be from the same institution as the author. Authors may indicate names of experts whom they wish to exclude as referees due to possible conflicts of interest.

Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Cells Tissues Organs' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

It is the author’s responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.



Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).



Format and Arrangement

Manuscripts should be written in English and be as concise as possible. Lines should be numbered on the margin.

Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head.
NB: Authors wishing to preserve the phonetic meaning of diacritics (PubMed reduces diacritics to their root characters) must spell their names accordingly when submitting manuscripts (e.g. Müller should be Mueller).

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

Key words: Please supply 3–10 key words in English that reflect the content of the paper.

Abstract: Each paper needs an abstract of a maximum of 250 words summarizing the essential new information communicated.

Subheadings: Introduction; Materials and Methods; Results; Discussion.

List of abbreviations: Provide on a separate page a list of the abbreviations used in your paper. The list will be printed as a footnote on the first page of your article.

Footnotes: With the exception of the list of abbreviations, footnotes should be avoided. When essential, they are numbered consecutively and typed at the foot of the appropriate page.

Nomenclature: The nomenclature used should conform, wherever possible, to the current edition of the Nomina Anatomica (Terminologia Anatomica), Nomina Anatomica Veterinaria, or to the Nomina Anatomica Avium.

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared as separate files. Tables require a heading and figures a legend, prepared on a separate page. Please only use scale bars to indicate magnifications of the illustrations. Due to technical reasons, figures with a screen background should not be submitted. W hen possible, group several illustrations on one block for reproduction (max. size 180 x 223 mm) or provide crop marks. Each illustration must be labelled with its number and the author's name. B/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800-1200 dpi. Figure files must not be embedded in a document file but submitted separately.



References

References in the text should be made by author’s name followed by the year of publication, arranged chronologically, then alphabetically. When there are more than two authors, use the first author’s name and et al. When references are made to more than one paper by the same author, published in the same year, designate them as a, b, c, etc. The list of references should include only those publications which are cited in the text. Material submitted for publication but not yet accepted may be cited in the text as ‘unpublished data’ but must not be included in the reference list. In the list of references, arrange references alphabetically listing all authors, then year of publication. Preferably, please cite all authors. Abbreviate journal names according to Index Medicus.
Examples

(a) Papers published in periodicals: Sun, J., H. Koto, K.F. Chung (1997) Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int Arch Allergy Immunol 112: 191–195.
Hadler, W.A., S.R. Silveira (1981) Técnica histoquímica que permite iscriminar o colesterol de substâncias afins e de seus ésteres. Cienc Cult 33(suppl): 586–587.

(b) Papers published only with DOI numbers: Theoharides, T.C., W. Boucher, K. Spear: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs: Matthews, D.E., V.T. Farewell (1996) Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger.

(d) Edited books: Parren, P.W.H.I., D.R. Burton (1997) Antibodies against HIV-1 from phage display libraries: Mapping of an immune response and progress towards antiviral immunotherapy; in Capra, J.D. (ed): Antibody Engineering. Chem Immunol. Basel, Karger, vol 65, pp 18–56.




Further Details

Authors may consult the 'Guide to Writing Articles in English' by R. O'Rahilly (Acta Anat 131: 1–2, 1988).




Proofs

Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer's errors are charged to the author. No page proofs are supplied.



Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org



Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.



Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.


Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.


Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.



Proofs

Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer's errors are charged to the author.



E-pub First

All articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference of the printed version. The articles become available immediately after the authors' approval to publication, with the added advantage of being citable much earlier than in print. Authors can influence the time of appearance by promptly returning the proofs.



Reprints

Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.